Overview

Gender

male

Klein has served as a Director of Isis since December 2005.

Klein is currently Managing Director of Gauss Capital Advisors, LLC, a financial consulting and investment advisory firm focused on biopharmaceuticals, which he founded in March 1998.

From September 2003 to December 2008, Klein also served as a Venture Partner of Red Abbey Venture Partners, L.P., a life science private equity fund. From September 2001 to September 2002, Klein was a Venture Partner of MPM Capital, a healthcare venture capital firm.

From June 1999 to September 2000 when it merged with WebMD Corporation, Klein served as Vice President, Strategy, for Medical Manager Corporation, a leading developer of physician office management information systems.

For over nine years from 1989 to 1998, Klein was a health care investment analyst at T. Rowe Price Associates, Inc., where he was the founding portfolio manager of the T. Rowe Price Health Sciences Fund, Inc.

Klein serves on the board of directors of The Prospector Funds, Inc., an SEC Registered Investment Company that manages two no-load mutual funds. Klein also serves on the boards of private and non-profit entities.

Within the last five years, Klein formerly served on the board of directors of five publicly held biotechnology companies: BioMarin Pharmaceutical Inc., NPS Pharmaceuticals, Inc., OSI Pharmaceuticals, Inc., PDL BioPharma, Inc. and Savient Pharmaceuticals, Inc.